Suppr超能文献

二肽基肽酶样蛋白6(DPPX)抗体相关脑炎:主要综合征及抗体作用

DPPX antibody-associated encephalitis: Main syndrome and antibody effects.

作者信息

Hara Makoto, Ariño Helena, Petit-Pedrol Mar, Sabater Lidia, Titulaer Maarten J, Martinez-Hernandez Eugenia, Schreurs Marco W J, Rosenfeld Myrna R, Graus Francesc, Dalmau Josep

机构信息

From the Clinical and Experimental Neuroimmunology Program (M.H., H.A., M.P.-P., L.S., E.M.-H., M.R.R., F.G., J.D.), August Pi Sunyer Biomedical Research Institute, Hospital Clínic, University of Barcelona, Spain; Division of Neurology (M.H.), Department of Medicine, Nihon University School of Medicine, Tokyo, Japan; Biomedical Research Networking Centre for Rare Diseases (H.A., J.D., M.P.-P., L.S., E.M.-H., M.R.R.), Valencia, Spain; Departments of Neurology (M.J.T.) and Immunology (M.W.J.S.), Erasmus Medical Center, Rotterdam, the Netherlands; Department of Neurology (M.R.R., J.D.), University of Pennsylvania, Philadelphia; and Catalan Institution for Research and Advanced Studies (J.D.), Barcelona, Spain.

出版信息

Neurology. 2017 Apr 4;88(14):1340-1348. doi: 10.1212/WNL.0000000000003796. Epub 2017 Mar 3.

Abstract

OBJECTIVE

To report the main syndrome of dipeptidyl-peptidase-like protein 6 (DPPX) antibody-associated encephalitis, immunoglobulin G (IgG) subclass, and the antibody effects on DPPX/Kv4.2 potassium channels.

METHODS

A retrospective analysis of new patients and cases reported since 2013 was performed. IgG subclass and effects of antibodies on cultured neurons were determined with described techniques.

RESULTS

Nine new patients were identified (median age 57 years, range 36-69 years). All developed severe prodromal weight loss or diarrhea followed by cognitive dysfunction (9), memory deficits (5), CNS hyperexcitability (8; hyperekplexia, myoclonus, tremor, or seizures), or brainstem or cerebellar dysfunction (7). The peak of the disease was reached 8 months (range 1-54 months) after onset. All patients had both IgG4 and IgG1 DPPX antibodies. In cultured neurons, the antibodies caused a decrease of DPPX clusters and Kv4.2 protein that was reversible on removal of the antibodies. Considering the current series and previously reported cases (total 39), 67% developed the triad: weight loss (median 20 kg; range 8-53 kg)/gastrointestinal symptoms, cognitive-mental dysfunction, and CNS hyperexcitability. Outcome was available from 35 patients (8 not treated with immunotherapy): 60% had substantial or moderate improvement, 23% had no improvement (most of them not treated), and 17% died. Relapses occurred in 8 of 35 patients (23%) and were responsive to immunotherapy.

CONCLUSIONS

DPPX antibodies are predominantly IgG1 and IgG4 and associate with cognitive-mental deficits and symptoms of CNS hyperexcitability that are usually preceded by diarrhea, other gastrointestinal symptoms, and weight loss. The disorder is responsive to immunotherapy, and this is supported by the reversibility of the antibody effects in cultured neurons.

摘要

目的

报告二肽基肽酶样蛋白6(DPPX)抗体相关脑炎的主要综合征、免疫球蛋白G(IgG)亚类以及抗体对DPPX/Kv4.2钾通道的影响。

方法

对2013年以来报告的新患者和病例进行回顾性分析。采用所述技术测定IgG亚类以及抗体对培养神经元的影响。

结果

确定了9例新患者(中位年龄57岁,范围36 - 69岁)。所有患者均先出现严重的前驱性体重减轻或腹泻,随后出现认知功能障碍(9例)、记忆缺陷(5例)、中枢神经系统(CNS)兴奋性增高(8例;惊跳反射亢进、肌阵挛、震颤或癫痫发作)或脑干或小脑功能障碍(7例)。发病后8个月(范围1 - 54个月)达到疾病高峰。所有患者均有IgG4和IgG1 DPPX抗体。在培养神经元中,抗体导致DPPX簇和Kv4.2蛋白减少,去除抗体后这种减少是可逆的。综合当前系列病例和先前报告的病例(共39例),67%的患者出现三联征:体重减轻(中位20 kg;范围8 - 53 kg)/胃肠道症状、认知 - 精神功能障碍和CNS兴奋性增高。35例患者(8例未接受免疫治疗)有预后数据:60%有显著或中度改善,23%无改善(其中大多数未接受治疗),17%死亡。35例患者中有8例(23%)复发,对免疫治疗有反应。

结论

DPPX抗体主要为IgG1和IgG4,与认知 - 精神缺陷以及CNS兴奋性增高症状相关,这些症状通常先于腹泻、其他胃肠道症状和体重减轻出现。该疾病对免疫治疗有反应,培养神经元中抗体作用的可逆性支持了这一点。

相似文献

1
DPPX antibody-associated encephalitis: Main syndrome and antibody effects.
Neurology. 2017 Apr 4;88(14):1340-1348. doi: 10.1212/WNL.0000000000003796. Epub 2017 Mar 3.
2
Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels.
Ann Neurol. 2013 Jan;73(1):120-8. doi: 10.1002/ana.23756. Epub 2012 Dec 7.
3
DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients.
Neurology. 2014 Nov 11;83(20):1797-803. doi: 10.1212/WNL.0000000000000991. Epub 2014 Oct 15.
4
Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies.
Neurology. 2014 Apr 29;82(17):1521-8. doi: 10.1212/WNL.0000000000000372. Epub 2014 Apr 2.
5
Anti-DPPX encephalitis: pathogenic effects of antibodies on gut and brain neurons.
Neurology. 2015 Sep 8;85(10):890-7. doi: 10.1212/WNL.0000000000001907. Epub 2015 Aug 19.
7
Case report: Ofatumumab treatment in anti-DPPX autoimmune encephalitis.
Front Immunol. 2024 Jun 27;15:1320608. doi: 10.3389/fimmu.2024.1320608. eCollection 2024.
10
Anti-dipeptidyl-peptidase-like protein 6 encephalitis with pure cerebellar ataxia: a case report.
BMC Neurol. 2022 Jul 1;22(1):242. doi: 10.1186/s12883-022-02769-0.

引用本文的文献

1
Case Report: Treatment of delayed tremor episodes in a patient with DPPX antibody encephalitis.
Front Immunol. 2025 Jul 30;16:1594823. doi: 10.3389/fimmu.2025.1594823. eCollection 2025.
3
Anti-dipeptidyl-peptidase-like protein-6 encephalitis with late-onset gastric cancer: A case report and 2-year follow-up.
Medicine (Baltimore). 2025 Feb 14;104(7):e41534. doi: 10.1097/MD.0000000000041534.
4
Clinical and Paraclinical Characterizations, Management, and Prognosis in DPPX Antibody-Associated Encephalitis: A Systematic Review.
Neurol Neuroimmunol Neuroinflamm. 2025 Mar;12(2):e200350. doi: 10.1212/NXI.0000000000200350. Epub 2024 Dec 18.
5
The Discovery of Autoimmune Nodopathies and the Impact of IgG4 Antibodies in Autoimmune Neurology.
Neurol Neuroimmunol Neuroinflamm. 2025 Jan;12(1):e200365. doi: 10.1212/NXI.0000000000200365. Epub 2024 Dec 13.
6
Decoding Autoimmune Autonomic Disorders: A Less-Recognized Overlap.
Ann Indian Acad Neurol. 2024 Sep 1;27(5):482-492. doi: 10.4103/aian.aian_394_24. Epub 2024 Oct 8.
7
Voltage Gated Ion Channels and Sleep.
J Membr Biol. 2024 Dec;257(5-6):269-280. doi: 10.1007/s00232-024-00325-0. Epub 2024 Oct 1.
8
9
Case report: Ofatumumab treatment in anti-DPPX autoimmune encephalitis.
Front Immunol. 2024 Jun 27;15:1320608. doi: 10.3389/fimmu.2024.1320608. eCollection 2024.
10
Expanding the clinical spectrum of anti-DPPX encephalitis: a multicenter retrospective study.
Front Neurosci. 2024 May 2;18:1379933. doi: 10.3389/fnins.2024.1379933. eCollection 2024.

本文引用的文献

1
Anti-LGI1-associated cognitive impairment: Presentation and long-term outcome.
Neurology. 2016 Aug 23;87(8):759-65. doi: 10.1212/WNL.0000000000003009. Epub 2016 Jul 27.
2
Human neurexin-3α antibodies associate with encephalitis and alter synapse development.
Neurology. 2016 Jun 14;86(24):2235-42. doi: 10.1212/WNL.0000000000002775. Epub 2016 May 11.
3
Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder.
JAMA Neurol. 2016 Jun 1;73(6):714-20. doi: 10.1001/jamaneurol.2016.0133.
4
Anti-DPPX encephalitis: pathogenic effects of antibodies on gut and brain neurons.
Neurology. 2015 Sep 8;85(10):890-7. doi: 10.1212/WNL.0000000000001907. Epub 2015 Aug 19.
5
The expanding field of IgG4-mediated neurological autoimmune disorders.
Eur J Neurol. 2015 Aug;22(8):1151-61. doi: 10.1111/ene.12758. Epub 2015 May 29.
6
Prednisolone and azathioprine are effective in DPPX antibody-positive autoimmune encephalitis.
Neurol Neuroimmunol Neuroinflamm. 2015 Mar 12;2(3):e86. doi: 10.1212/NXI.0000000000000086. eCollection 2015 Jun.
7
Neuropathologic features of anti-dipeptidyl-peptidase-like protein-6 antibody encephalitis.
Neurology. 2015 Jan 27;84(4):430-2. doi: 10.1212/WNL.0000000000001183. Epub 2014 Dec 17.
8
DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients.
Neurology. 2014 Nov 11;83(20):1797-803. doi: 10.1212/WNL.0000000000000991. Epub 2014 Oct 15.
9
Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes.
Brain. 2014 Aug;137(Pt 8):2178-92. doi: 10.1093/brain/awu142. Epub 2014 Jun 20.
10
Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis.
Ann Neurol. 2014 Jul;76(1):108-19. doi: 10.1002/ana.24195. Epub 2014 Jun 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验